Telmisartan: a review of its use in the management of hypertension (Q46883816)

26 December 2017

review article

1 reference

title

Telmisartan: a review of its use in the management of hypertension (English)

1 reference

26 December 2017

2

Lesley J Scott

1 reference

26 December 2017

Anna J Battershill

1

1 reference

26 December 2017

publication date

1 January 2006

1 reference

26 December 2017

published in

Drugs

1 reference

26 December 2017

volume

66

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

51-83

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.2165/00003495-200666010-00004

exact match

0 references

cites work

Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety

1 reference

12 December 2020

The comparative pharmacology of angiotensin II receptor antagonists

1 reference

12 December 2020

Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension

1 reference

12 December 2020

The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I).

1 reference

12 December 2020

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

12 December 2020

The normal circadian pattern of blood pressure: implications for treatment.

1 reference

12 December 2020

Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study

1 reference

12 December 2020

Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property

1 reference

12 December 2020

Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan

1 reference

12 December 2020

Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients

1 reference

12 December 2020

Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan

1 reference

12 December 2020

The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers

1 reference

12 December 2020

Dose response and safety of telmisartan in patients with mild to moderate hypertension

1 reference

12 December 2020

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

1 reference

12 December 2020

Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension

1 reference

12 December 2020

Epidemiology of uncontrolled hypertension in the United States

1 reference

12 December 2020

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

12 December 2020

Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers

1 reference

12 December 2020

A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring

1 reference

12 December 2020

Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients

1 reference

12 December 2020

Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

1 reference

12 December 2020

Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

1 reference

12 December 2020

Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension

1 reference

12 December 2020

Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients

1 reference

12 December 2020

The adjunctive effect of telmisartan in patients with hypertension uncontrolled on current antihypertensive therapy.

1 reference

12 December 2020

Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring

1 reference

12 December 2020

Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers

1 reference

12 December 2020

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

12 December 2020

Blood-pressure control in the hypertensive population

1 reference

12 December 2020

Effects of telmisartan and losartan on left ventricular mass in mild-to-moderate hypertension. A randomized, double-blind trial

1 reference

12 December 2020

A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine

1 reference

12 December 2020

Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers

1 reference

12 December 2020

The role of angiotensin II receptor antagonists in the management of diabetes

1 reference

12 December 2020

The telmisartan Programme of Research tO show Telmisartan End-organ proteCTION (PROTECTION) Programme

1 reference

12 December 2020

Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.

1 reference

12 December 2020

Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.

1 reference

12 December 2020

Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study

1 reference

12 December 2020

Blood pressure lowering and renin-angiotensin system blockade

1 reference

12 December 2020

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study

1 reference

12 December 2020

Early target organ damage and its reversibility: the heart.

1 reference

12 December 2020

Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications

1 reference

12 December 2020

Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension.

1 reference

12 December 2020

Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo

1 reference

12 December 2020

Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers

1 reference

12 December 2020

Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension

1 reference

12 December 2020

The circadian pattern of blood pressure: cardiovascular risk and therapeutic opportunities

1 reference

12 December 2020

Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized,

1 reference

12 December 2020

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

1 reference

12 December 2020

Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge

1 reference

12 December 2020

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

1 reference

12 December 2020

The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?

1 reference

12 December 2020

Effect of 24-week treatment with telmisartan on myocardial structure and function: relationship to insertion/deletion polymorphism of the angiotensin-converting enzyme gene

1 reference

12 December 2020

Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study

1 reference

12 December 2020

Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension

1 reference

12 December 2020

Nephropathy in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.

1 reference

12 December 2020

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

12 December 2020

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

12 December 2020

Pathogenesis and clinical physiology of hypertension

1 reference

12 December 2020

Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension

1 reference

12 December 2020

Telmisartan: a review of its use in hypertension

1 reference

12 December 2020

Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension

1 reference

12 December 2020

Safety of telmisartan in patients with arterial hypertension : an open-label observational study

1 reference

12 December 2020

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

12 December 2020

Sustained antihypertensive activity of telmisartan compared with valsartan

1 reference

12 December 2020

The cardiovascular continuum and renin-angiotensin-aldosterone system blockade

1 reference

12 December 2020

Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients

1 reference

12 December 2020

An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.

1 reference

12 December 2020

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

1 reference

12 December 2020

Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists

1 reference

12 December 2020

Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers

1 reference

12 December 2020

Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study

1 reference

12 December 2020

Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study

1 reference

12 December 2020

The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group

1 reference

12 December 2020

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

1 reference

12 December 2020

Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives

1 reference

12 December 2020

Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain

1 reference

12 December 2020

Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan

1 reference

12 December 2020

ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada

1 reference

12 December 2020

Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study

1 reference

12 December 2020

Effects on binding characteristics and renal function of the novel, non-peptide angiotensin II antagonist BIBR277 in the rat

1 reference

12 December 2020

Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.

1 reference

12 December 2020

Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension

1 reference

12 December 2020

Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period

1 reference

12 December 2020

The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension

1 reference

12 December 2020

Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension

1 reference

12 December 2020

Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial

1 reference

12 December 2020

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

12 December 2020

Managing the patient at risk for a second stroke.

1 reference

12 December 2020

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

1 reference

12 December 2020

10.2165/00003495-200666010-00004

Identifiers

DOI

1 reference

26 December 2017

Dimensions Publication ID

0 references

1 reference

26 December 2017